What 8 Analyst Ratings Have To Say About NXP Semiconductors
NXP Semiconductors (NASDAQ:NXPI) has observed the following analyst ratings within the last quarter:
Argus Research Initiates Coverage On NXP Semiconductors with Buy Rating, Announces Price Target of $260
Argus Research analyst Jim Kelleher initiates coverage on NXP Semiconductors (NASDAQ:NXPI) with a Buy rating and announces Price Target of $260.
‘Halftime Report’ Traders Weigh In On Shopify, Uber And More
Jim Lebenthal said on CNBC's "Fast Money Halftime Report," that NXP Semiconductors NV (NASDAQ: NXPI) is definitively a buy here.
4 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs.
Cathie Wood’s ARK Invest Posts Fund Sales For Friday, Aug. 13, 2021: VEEV, SRPT, SEER, PTSI, MCRB, IOVA, NXPI
Veeva Systems (VEEV) - 17,020
Sarepta Therapeutics (SRPT) - 44,038
Seer (SEER) - 224,574
Pluristem Therapeutics (PTSI) - 100
Seres Therapeutics (MCRB) - 14,751
Iovance Therapeutics (IOVA)
‘Fast Money Halftime Report’ Picks For August 4
On CNBC's "Fast Money Halftime Report," Liz Young picked iShares US Healthcare ETF (NYSE: IYH) as her final trade on Wednesday. She likes it because it is not definitively a growth or value place.